Skip to main content
Top
Published in: Abdominal Radiology 7/2016

01-07-2016

Clinical application of navigator-gated three-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 1.5 T

Authors: Ryo Itatani, Tomohiro Namimoto, Syutaro Atsuji, Kazuhiro Katahira, Yasuyuki Yamashita

Published in: Abdominal Radiology | Issue 7/2016

Login to get access

Abstract

Objective

To evaluate and compare the clinical utility of balanced turbo-field-echo (BTFE) magnetic resonance cholangiopancreatography (MRCP) sequences obtained at 3 and 1.5 T.

Methods

We acquired three-dimensional (3D) BTFE MRCP scans with a navigator-gated technique at 3 T on a different day after 1.5 T in 39 consecutive patients. Two radiologists independently rated the image quality and visibility of anatomical structures (right and left hepatic duct, cystic duct, gallbladder, common bile duct, and main pancreatic duct) using a four-point scale. For quantitative analysis, the signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and acquisition time were evaluated.

Results

All visual scores tended to be higher for 1.5 T than 3 T images. There was a significant difference in the image quality and the depiction of the main pancreatic duct (p < 0.01). The image acquisition time was significantly shorter for 3 T than 1.5 T (199.3 ± 40.1 vs. 264.0 ± 86.5 s, p < 0.01). There was no significant difference in SNR and CNR.

Conclusions

3D-BTFE MRCP scans acquired at 3 T were of sufficient image quality with respect to the biliary tree. SNR and CNR were comparable on 3 and 1.5 T scans, although the acquisition time was significantly shorter with the 3 T scanner.
Literature
1.
go back to reference Taylor AC, Little AF, Hennessy OF, et al. (2002) Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc 55:17–22CrossRefPubMed Taylor AC, Little AF, Hennessy OF, et al. (2002) Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc 55:17–22CrossRefPubMed
2.
go back to reference Limanond P, Raman SS, Ghobrial RM, et al. (2004) The utility of MRCP in preoperative mapping of biliary anatomy in adult-to-adult living related liver transplant donors. J Magn Reson Imaging 19:209–215CrossRefPubMed Limanond P, Raman SS, Ghobrial RM, et al. (2004) The utility of MRCP in preoperative mapping of biliary anatomy in adult-to-adult living related liver transplant donors. J Magn Reson Imaging 19:209–215CrossRefPubMed
3.
go back to reference Sodickson A, Mortele KJ, Barish MA, et al. (2006) Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 238:549–559CrossRefPubMed Sodickson A, Mortele KJ, Barish MA, et al. (2006) Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology 238:549–559CrossRefPubMed
4.
go back to reference Nakaura T, Kidoh M, Maruyama N, et al. (2013) Usefulness of the SPACE pulse sequence at 1.5T MR cholangiography: comparison of image quality and image acquisition time with conventional 3D-TSE sequence. J Magn Reson Imaging 38:1014–1019CrossRefPubMed Nakaura T, Kidoh M, Maruyama N, et al. (2013) Usefulness of the SPACE pulse sequence at 1.5T MR cholangiography: comparison of image quality and image acquisition time with conventional 3D-TSE sequence. J Magn Reson Imaging 38:1014–1019CrossRefPubMed
5.
go back to reference Arizono S, Isoda H, Maetani YS, et al. (2008) High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging 28:685–690CrossRefPubMed Arizono S, Isoda H, Maetani YS, et al. (2008) High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging 28:685–690CrossRefPubMed
6.
go back to reference Arizono S, Isoda H, Maetani YS, et al. (2010) High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T. Eur J Radiol 73:114–118CrossRefPubMed Arizono S, Isoda H, Maetani YS, et al. (2010) High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T. Eur J Radiol 73:114–118CrossRefPubMed
7.
go back to reference Itatani R, Namimoto T, Kajihara H, et al. (2013) Preoperative evaluation of the cystic duct for laparoscopic cholecystectomy: comparison of navigator-gated prospective acquisition correction- and conventional respiratory-triggered techniques at free-breathing 3D MR cholangiopancreatography. Eur Radiol 23:1911–1918CrossRefPubMed Itatani R, Namimoto T, Kajihara H, et al. (2013) Preoperative evaluation of the cystic duct for laparoscopic cholecystectomy: comparison of navigator-gated prospective acquisition correction- and conventional respiratory-triggered techniques at free-breathing 3D MR cholangiopancreatography. Eur Radiol 23:1911–1918CrossRefPubMed
8.
go back to reference Matsunaga K, Ogasawara G, Tsukano M, et al. (2012) Usefulness of the navigator-echo triggering technique for free-breathing three-dimensional magnetic resonance cholangiopancreatography. Magn Reson Imaging 31:396–400CrossRefPubMed Matsunaga K, Ogasawara G, Tsukano M, et al. (2012) Usefulness of the navigator-echo triggering technique for free-breathing three-dimensional magnetic resonance cholangiopancreatography. Magn Reson Imaging 31:396–400CrossRefPubMed
9.
go back to reference Glockner JF, Lee CU (2014) Balanced steady state-free precession (b-SSFP) imaging for MRCP: techniques and applications. Abdom Imaging 39:1309–1322CrossRefPubMed Glockner JF, Lee CU (2014) Balanced steady state-free precession (b-SSFP) imaging for MRCP: techniques and applications. Abdom Imaging 39:1309–1322CrossRefPubMed
10.
go back to reference Glockner JF, Saranathan M, Bayram E, et al. (2013) Breath-held MR cholangiopancreatography (MRCP) using a 3D Dixon fat-water separated balanced steady state free precession sequence. Magn Reson Imaging 31:1263–1270CrossRefPubMedPubMedCentral Glockner JF, Saranathan M, Bayram E, et al. (2013) Breath-held MR cholangiopancreatography (MRCP) using a 3D Dixon fat-water separated balanced steady state free precession sequence. Magn Reson Imaging 31:1263–1270CrossRefPubMedPubMedCentral
11.
go back to reference Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946–959CrossRefPubMed Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946–959CrossRefPubMed
12.
go back to reference Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. Am J Roentgenol 186:1524–1532CrossRef Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. Am J Roentgenol 186:1524–1532CrossRef
13.
go back to reference Kuhl CK, Traber F, Schild HH (2008) Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part I. Technical considerations and clinical applications. Radiology 246:675–696CrossRefPubMed Kuhl CK, Traber F, Schild HH (2008) Whole-body high-field-strength (3.0-T) MR imaging in clinical practice. Part I. Technical considerations and clinical applications. Radiology 246:675–696CrossRefPubMed
14.
go back to reference Merkle EM, Haugan PA, Thomas J, et al. (2006) 3.0-versus 1.5-T MR cholangiography: a pilot study. Am J Roentgenol 186:516–521CrossRef Merkle EM, Haugan PA, Thomas J, et al. (2006) 3.0-versus 1.5-T MR cholangiography: a pilot study. Am J Roentgenol 186:516–521CrossRef
15.
go back to reference O’Regan DP, Fitzgerald J, Allsop J, et al. (2005) A comparison of MR cholangiopancreatography at 1.5 and 3.0 Tesla. Br J Radiol 78:894–898CrossRefPubMed O’Regan DP, Fitzgerald J, Allsop J, et al. (2005) A comparison of MR cholangiopancreatography at 1.5 and 3.0 Tesla. Br J Radiol 78:894–898CrossRefPubMed
16.
go back to reference Isoda H, Kataoka M, Maetani Y, et al. (2007) MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging 25:1000–1006CrossRefPubMed Isoda H, Kataoka M, Maetani Y, et al. (2007) MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging 25:1000–1006CrossRefPubMed
17.
go back to reference Itatani R, Namimoto T, Takaoka H, et al. (2015) Clinical impact of 3-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 3-dimensional turbo-spin-echo magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 39:19–24CrossRefPubMed Itatani R, Namimoto T, Takaoka H, et al. (2015) Clinical impact of 3-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 3-dimensional turbo-spin-echo magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 39:19–24CrossRefPubMed
18.
go back to reference Lanzman RS, Kropil P, Schmitt P, et al. (2012) Nonenhanced ECG-gated time-resolved 4D steady-state free precession (SSFP) MR angiography (MRA) of cerebral arteries: comparison at 1.5 T and 3 T. Eur J Radiol 81:e531–e535CrossRefPubMed Lanzman RS, Kropil P, Schmitt P, et al. (2012) Nonenhanced ECG-gated time-resolved 4D steady-state free precession (SSFP) MR angiography (MRA) of cerebral arteries: comparison at 1.5 T and 3 T. Eur J Radiol 81:e531–e535CrossRefPubMed
19.
go back to reference Zho SY, Park J, Choi JY, et al. (2010) Respiratory motion compensated MR cholangiopancreatography at 3.0 Tesla. J Magn Reson Imaging 32:726–732CrossRefPubMed Zho SY, Park J, Choi JY, et al. (2010) Respiratory motion compensated MR cholangiopancreatography at 3.0 Tesla. J Magn Reson Imaging 32:726–732CrossRefPubMed
Metadata
Title
Clinical application of navigator-gated three-dimensional balanced turbo-field-echo magnetic resonance cholangiopancreatography at 3 T: prospective intraindividual comparison with 1.5 T
Authors
Ryo Itatani
Tomohiro Namimoto
Syutaro Atsuji
Kazuhiro Katahira
Yasuyuki Yamashita
Publication date
01-07-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0633-3

Other articles of this Issue 7/2016

Abdominal Radiology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.